CARDIOVASCULAR JOURNAL OF AFRICA • Volume 34, No 3, July/August 2023 AFRICA 147 in community pharmacies in Nigeria: a cross sectional study. Int J Clinic Pharma 2020; 42(6): 1469–1479. 12. Mensah GA, Brown DW. An overview of cardiovascular burden in the US. Health Aff 2003; 26(1): 38–48. 13. Mushabab A, Al-Ghamdi, Aref A, Abdulhak B. Pattern, duration of stay, and outcomes of medical admissions: a report from teaching community hospital in Asia region, Saudi Arabia. J Comm Hosp Int Med Persp 2018; 8(2); 53–56. 14. Oyoo GO, Ogola EN. Clinical and sociodemographic aspects of congestive heart failure patients at Kenyatta National Hospital, Nairobi. East Afr Med J 1999; 76: 23–27. 15. Antony KK. Pattern of cardiac failure in northern savanna Nigeria. Trop Geogr Med 1980; 32: 118–125. 16. Odenigbo CU, Oguejiofor OC. Pattern of medical admissions at the Federal Medical Centre, Asaba – a two-year review. Nig J Clin Pract 2009; 12(4); 395–397. 17. Ike SO. The pattern of admissions into the medical wards of the University of Nigeria Teaching Hospital, Enugu. Nig J Clin Pract 2008; 11(3): 185–192. 18. Ansa VO, Ekott JU, Bassey EO. Profile and outcome of cardiovascular admissions at the University of Uyo Teaching Hospital, Uyo – a five-year review. Nig J Clin Pract 2008; 11(1): 22–24. 19. Lagos population data. http://worldpopulationreview.com/world-cities/ lagos-population/. 20. Mbakwem AC, Oke DA, Ajuluchukwu JNA, Abdulkareem FB, Ale O, Odunlami K. Trends in acute emergency room deaths: an autopsy study. Nig J Clin Pract 2009; 12: 15–19. 21. International Classification of Diseases, 9th edn. Clinical Modification. https://www.cdc.gov/nchs/icd/icd9cm.htm. 22. Osuji CU, Onwubuya EI, Ahaneku GI, Omejua EG. Pattern of cardiovascular admissions at the Nnamdi Azikiwe University Teaching Hospital, Nnewi South East Nigeria. Pan-Afr Med J 2014; 17: 116. 23. Oguanobi NI, Ejim EC, Onwubere BJ, Ike SO, Anisiuba BC, Ikeh VO, Aneke EO. Pattern of cardiovascular disease amongst medical admissions in a regional teaching hospital in South-eastern Nigeria. Nig J Cardiol 2013; 10: 77–80. 24. Hadiza S. Cardiovascular Disease admissions in medical wards of a tertiary hospital in north-west Nigeria. IOSR J Dent Med Sci 2018; 17(5): 47–50. 25. Appiah LT, Sarfo FS, Agyemang C, Tweneboah HO, Appiah NA, BeduAddo, G et al. Current trends in admissions and outcomes of cardiac diseases in Ghana. Clin Cardiol 2017; 40: 783–788. 26. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001; 104(22): 2746–2753. 27. Ojji DB, Stewart S, Ajayi S, Manmak M, Sliwa K. A predominance of hypertensive heart failure in the Abuja Heart Study cohort of urban Nigerians: a prospective clinical registry of 1515 de novo cases. Eur J Heart Fail 2013; 15(8): 835–842. 28. Karaye KM, Mahmoud SU. Factors associated with poor prognosis among patients admitted with heart failure in a Nigerian tertiary medical centre: a cross-sectional study. BMC Cardiovasc Disord 2008; 8: 16. 29. Ogunmola O, Akintomide A. Mortality pattern of cardiovascular diseases in the medical wards of a tertiary health centre in a rural area of Ekiti State, Southwest Nigeria. Asian J Med Sci 2013; 4(3): 52–57. 30. Nwafor CE, Alikor A. Pattern of cardiovascular disease admissions in the medical wards of the University of Port Harcourt Teaching Hospital: a retrospective review. Nig Health J 2016; 16(2). 31. Adedapo AD. Rising trend of cardiovascular diseases among SouthWestern Nigerian female patients. Nig J Cardiol 2017; 14: 71–74. 32. Eze CO, Agu CE, Kalu UA, Maduanusi CA, Nwali ST, Igwenyi C. Pattern of medical admissions in a tertiary health centre in Abakaliki, South East Nigeria. J Biol Agric Healthcare 2013; 3(12): 1–6. 33. Amoah AG, Kallen C. Aetiology of heart failure as seen from a national cardiac referral centre in Africa. Cardiology 2000; 93: 11–18. 34. Owusu IK, Boakye YA. Prevalence and aetiology of heart failure in patients seen at a teaching hospital in Ghana. J Cardiovasc Dis Diagn 2013; 1: 131. 35. Oyoo GO, Ogola EN. Clinical and socio-demographic aspects of congestive heart failure patients at Kenyatta National Hospital, Nairobi. East Afr Med J 1999; 76(1): 23–27. 36. Walker RW, Jusabani A, Aris E, Gray WK, Unwin N, Swai M, et al. Stroke risk factors in an incident population in urban and rural Tanzania: a prospective, community-based, case-control study. Lancet Glob Health 2013; 1(5): e282–288. 37. Owolabo MO, Sarfo F, Akinyem R, Gebregziabher M, Akpa O, Akpalu A, et al. Dominant modifiable risk factors for stroke in Ghana and Nigeria (SIREN): a case-control study. Lancet Glob Health 2018; 6: e436–446. 38. O’Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet 2016; 388: 761–775. 39. Ekeh B, Ogunniyi A, Isamade E, Erikpo E. Stroke mortality and its predictors in a Nigerian teaching hospital. Afr Health Sci 2015; 15(1); 74–81. 40. Sanya EO, Wahab K W, Bello A H, Alaofin W A, Ademiluyi B A. In-hospital stroke mortality and its predictors within one month of ictus: Result from a tertiary hospital in Ilorin, middle belt Nigeria. Sub-Saharan Afr J Med 2015; 2: 165–169. 41. Ogah OS, Arije A, Xin X, Beaney T, Adebiyi A, Sani, MU, et al. May Measurement Month 2017: screening for hypertension in Nigeria – subSaharan Africa. Eur Heart J 2019; 21(Suppl D): D86–D88. 42. Okubadejo NU, Ozoh OB, Ojo OO, Akinkugbe AO, Odeniyi IA, Afegoke O, et al. Prevalence of hypertension and blood pressure profile among urban-dwelling adults in Nigeria: a comparative analysis of recent guideline recommendations. Clin Hypertens 2019; 25: 7. 43. Odili AN, Chori BS, Danladi B, Nwakile PC, Okoye IC, Abdullahi U, et al. Prevalence, awareness, treatment and control of hypertension in Nigeria: Data from a nationwide survey 2017. Glob Heart 2020; 15(1): 47. 44. Amadi CE, Adeyemi OA, Joda AE, Mbakwem AC, Ajuluchukwu JN. Self-reported adherence to anti-hypertensive drugs in a Nigerian population using the Morisky Medication Adherence Scale. Nig Q J Hosp Med 2014; 24(2): 145–149. 45. Davey S, Neaton JD, Wentworth D, Stamler R, Stamler J. Mortality differences between black and white men in the US. Contribution of income and other risk factors among men screened for the MRFIT. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Lancet 1998; 351: 934–939. 46. Mancia G, Parati G, Borghi C, Ghironzi G, et al. Smooth investigators. Hypertension prevalence, awareness, control and association with metabolic abnormalities in San Maniano population the SMOOTH Study. J Hypertens 2006; 24: 837–843. 47. Mancia G,Bombelli M, Corrao G, Facchetti R, Madotto F, et al. Metabolic syndrome in the PAMELA study: daily life blood pressure, cardiac damage, and prognosis. Hypertension 2007; 49: 40–47. 48. Mancia G, Grassi G. Systolic and diastolic blood pressure control in antihypertensive drug trials. J Hypertens 2007; 20: 1461–1464. 49. Damasceno A, Mayosi BM, Mahmoud S, Ogah OS, Mondo C, Ojji D,
RkJQdWJsaXNoZXIy NDIzNzc=